At what point did selling orthopedic products stop being about clinical value and patient outcomes—transforming entirely into a game of wrangling access, locking down contracts, and navigating the bureaucratic maze of VACs?
Read the best 8 answers from my posting of this question.
1/ When achieving quota became the priority placing shareholders before patients. (from https://www.linkedin.com/in/chuck-raggio-pe-10383229/)
2/ Two spots in time... When hospitals merged and became health systems and when surgeons (roughly 2 in 3) sold their practices to these health systems. (from https://www.linkedin.com/in/mark-copeland-50712b4/)
3/ When reps started confusing customer service for sales Tiger Buford (from https://www.linkedin.com/in/mark-copeland-50712b4/)
4/ It's also because ASCs flat out say "we need this kind of price because of our lower reimbursement" and if you give it to them, they let you in. So companies do it and start doing cases. It's collaborative still, for the most part. (from https://www.linkedin.com/in/mark-copeland-50712b4/)
5/ Hospitals don't do that anymore. You give it to them and they STILL don't let you in. They actually ignore you for the most part.
When sur...
